08.09.16
ClinTec International has appointed Alastair MacDonald global head of clinical operations.
Mr. MacDonald joins ClinTec from AstraZeneca with almost 25 years’ experience in clinical development, most recently, as global medical evidence and observational research director at AstraZeneca. As a global delivery director within AstraZeneca, he made key contributions to the development pipeline and commercialization, with a focus on oncology, and within other key strategic AstraZeneca areas including cardiovascular, metabolic and respiratory medicine. His significant oncology background includes recent contributions to the development and subsequent commercialization of a number of key treatments across a broad range of cancer diseases.
In addition, Mr. MacDonald was a board director of the Institute of Clinical Research (ICR), an organization responsible for education, training and career development of clinical research professionals in the UK. In 2013 he was awarded an Honorary Fellowship of the ICR.
“As our company enters its 20th year of significant organic growth, we are delighted to have attracted Alastair to ClinTec International and look forward to bringing his industry leading operational talent and high caliber to bear in providing complementary leadership to our award winning clinical research project teams,” said Robert Reekie, chief operating officer and senior executive vice president, ClinTec. “In conjunction with our e-clinical technology platforms, this appointment further enhances our capability to meet and exceed the needs of our clients.”
Mr. MacDonald joins ClinTec from AstraZeneca with almost 25 years’ experience in clinical development, most recently, as global medical evidence and observational research director at AstraZeneca. As a global delivery director within AstraZeneca, he made key contributions to the development pipeline and commercialization, with a focus on oncology, and within other key strategic AstraZeneca areas including cardiovascular, metabolic and respiratory medicine. His significant oncology background includes recent contributions to the development and subsequent commercialization of a number of key treatments across a broad range of cancer diseases.
In addition, Mr. MacDonald was a board director of the Institute of Clinical Research (ICR), an organization responsible for education, training and career development of clinical research professionals in the UK. In 2013 he was awarded an Honorary Fellowship of the ICR.
“As our company enters its 20th year of significant organic growth, we are delighted to have attracted Alastair to ClinTec International and look forward to bringing his industry leading operational talent and high caliber to bear in providing complementary leadership to our award winning clinical research project teams,” said Robert Reekie, chief operating officer and senior executive vice president, ClinTec. “In conjunction with our e-clinical technology platforms, this appointment further enhances our capability to meet and exceed the needs of our clients.”
